Mechanism ColonBroom's GLP-1 positioning is backed by real fiber science: fermentable fiber increases short-chain fatty acids, which activate receptors on gut L-cells that release GLP-1 and PYY, both of which increase fullness
What your employees get with Wondr+ Proven, evidence-based digital behavioral program Personalized lifestyle and condition-specific content tracks Group and 1:1 coaching with 24/7 wraparound community support Configurable options GLP-1 access and clinician visits (100% employee self-pay) In-network nutrition services Connected scales 5.2% Average weight loss for employees with Wondr+ WONDR ADVANCED What your employees get with Wondr Advanced All features of Wondr+ Configurable funding strategies for anti-obesity medications Access to obesity specialists for medication management Tracking of adherence, behaviors, and outcomes Personalized skill-checks, content, and community for medical weight loss Configurable options GLP-1 access (100% employee self-pay or cost-share) In-network nutrition services Connected scales 20%+ Average weight loss for employees with Wondr Advanced Built for employers who want corporate weight loss programs that cut healthcare costs
Even for people who use GLP-1 agonists, unless they adopt a healthy lifestyle while taking these drugs, when they stop taking the drugs they gain the weight back. What to Avoid in Weight Loss Pills Weight loss pills have historically been fraught with issues
Personalized Dosing: Why Genetics and Baseline Status Matter PlexusDx's Precision Peptide Genetic Test analyzes variants in GIPR and FTO, and MC4R genesmarkers that influence how your body responds to GLP-1 class drugs and processes fat metabolism
